Atlas Trials

Single-cell Sequencing Analysis of Resectable/Borderline Resectable Pancreatic Cancer Patients

Clinical trial NCT06310902 · RECRUITING

Trial details

NCT number
NCT06310902
Sponsor
Fujian Medical University Union Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Pancreatic Neoplasms
Start date
2024-03-01
Primary completion
2026-03-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.